Find expertise
Ward Sents KU Leuven
Dorien Haesen KU Leuven
Ria Kleppe KU Leuven
Jozef Goris KU Leuven
Katrien Van Roosbroeck KU Leuven
Biocrystallography KU Leuven
Responsible
The design of new potential drugs is traditionally the domain of the pharmacochemist. In the last decades Quantitative Structure-Activity Relationship (QSAR)-techniques are used more and more to define the 'essential' moieties of a pharmacon. A logical evolution in the search for the relation between the 3D-structure of drugs & their biological activity is the 3D-structure analysis of the biological target molecules and the receptor- ...